CenterBook Partners LP Trims Position in Ventas, Inc. $VTR

CenterBook Partners LP trimmed its position in Ventas, Inc. (NYSE:VTR) by 39.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 10,846 shares of the real estate investment trust’s stock after selling 7,088 shares during the period. CenterBook Partners LP’s holdings in Ventas were worth $759,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently made changes to their positions in VTR. Cloud Capital Management LLC bought a new stake in Ventas during the third quarter valued at approximately $25,000. True Wealth Design LLC lifted its position in Ventas by 1,557.7% during the third quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock valued at $30,000 after purchasing an additional 405 shares in the last quarter. ORG Partners LLC grew its holdings in Ventas by 76.1% during the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock valued at $32,000 after purchasing an additional 197 shares during the period. Wilmington Savings Fund Society FSB increased its position in Ventas by 65.5% in the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock worth $32,000 after buying an additional 180 shares in the last quarter. Finally, Golden State Wealth Management LLC raised its stake in shares of Ventas by 52.7% in the second quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock worth $34,000 after buying an additional 185 shares during the period. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Price Performance

VTR opened at $85.87 on Friday. The business has a fifty day moving average of $79.25 and a 200 day moving average of $74.50. The stock has a market cap of $40.78 billion, a P/E ratio of 159.01, a PEG ratio of 2.10 and a beta of 0.77. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. Ventas, Inc. has a 52-week low of $60.15 and a 52-week high of $87.24.

Ventas (NYSE:VTR) last released its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). The business had revenue of ($1,229.71) million for the quarter, compared to the consensus estimate of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.The firm’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, sell-side analysts anticipate that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. This is a boost from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. Ventas’s dividend payout ratio is 355.56%.

Insider Activity

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of Ventas stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total transaction of $801,606.52. Following the completion of the sale, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. The trade was a 0.92% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Robert F. Probst sold 29,930 shares of the company’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total value of $2,312,092.50. Following the completion of the sale, the chief financial officer owned 138,434 shares of the company’s stock, valued at $10,694,026.50. This represents a 17.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 86,106 shares of company stock valued at $6,931,397. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

VTR has been the subject of several analyst reports. Citigroup increased their target price on shares of Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Wednesday, February 11th. Jefferies Financial Group reissued a “buy” rating and issued a $93.00 price objective on shares of Ventas in a research note on Monday, December 15th. Weiss Ratings upgraded shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Argus set a $88.00 price target on Ventas in a research note on Tuesday, February 10th. Finally, KeyCorp boosted their price objective on Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Ventas currently has a consensus rating of “Moderate Buy” and a consensus target price of $86.87.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.